The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, February 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 78 Dimensions

Readers on

mendeley: 112 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 338 followers.

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior t... https://t.co/M6pkBQkHUU #GE01

Reply Repost Favourite

Tiotropium plus olodaterol 24 hour lung function profile https://t.co/2leO5kLNip

Reply Repost Favourite